Market Research & Insights
Clarivate patient centricity report underscores need for evolution from selling products to building relationships
Clarivate, a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the release […]
MoreMarket Research & Insights
The future of the generics landscape: Key branded drugs losing exclusivity in 2021 and beyond
Clarivate, a global leader in providing trusted information and insights to accelerate the pace of innovation, announced the launch of […]
MoreMarket Research & Insights
Patient centricity has long been at the heart of medical innovation, but today shapes its future
Clarivate, a global leader in providing trusted information and insights to accelerate the pace of innovation, announced the launch of […]
MoreMarket Research & Insights
Clarivate forecasts nearly 70% of Asia Pacific, North American and European adult populations will be vaccinated for COVID-19 by September 2021
A new report analyses how the emergence and increased availability of vaccines will impact the recovery of healthcare markets across […]
MoreMarket Research & Insights
2021 outlook for pharma mergers and acquisitions
Market Research & Insights: A recent PwC report indicated an optimistic 2021 for the pharmaceutical and life sciences (PLS) sector […]
MoreMarket Research & Insights
What high-performing MedTech companies are doing differently
Market Research & Insights: Innovation and product development (I&PD) in the MedTech sector is costly. A strong I&PD strategy can help […]
MoreMarket Research & Insights
New report identifies skills priorities for future workforce of Pharma, MedTech and Biotech
Market Research & Insights
MedTech leaders prioritise innovation and technology
Please log in to Health Industry Hub to view this content in the Market Research & Insights menu.
Market Research & Insights
Workforce gaps in Australian MedTech, Pharma, Biotech and digital health sectors
Australia’s medical technology, biotechnology, pharmaceutical and digital health sector supports approximately 70,000 Australian jobs and contributed more than $5 billion […]
MoreMarket Research & Insights
New report highlights impact of COVID-19 on cancer screening
Please log in to Health Industry Hub to view this content in the Medical sub-menu.
Recent Posts in Pharma, MedTech & Biotech
NACCHO-Pfizer partnership ignites global journey for First Nations pharmacy leaders
September 6, 2024
in Medical and Science
First report exposes glaring gaps in healthcare sector sustainability
September 6, 2024
in ESG
Expanded access to Shingrix is a start: ‘We need reform for all current and future vaccines’
September 6, 2024
in News & Trends - Pharmaceuticals
NSW government fails to back mental health inquiry findings with essential funding
September 6, 2024
in News & Trends - Pharmaceuticals
More Aussies cut back on GP visits, medicines and diagnostics due to financial strain
September 5, 2024
in News & Trends - Pharmaceuticals
Health Minister rules out taxpayer bailout for private hospitals amidst financial crisis
September 5, 2024
in News & Trends - MedTech & Diagnostics
Digital care model improves diabetes life expectancy, paving way for new partnership in clinical trials
September 5, 2024
in Medical and Science
Victorian health crisis: Nearly half a billion dollar emergency funding to cover hospital staff salaries
September 5, 2024
in News & Trends - MedTech & Diagnostics
Follow Us
Partner with us
Medical and Science
NACCHO-Pfizer partnership ignites global journey for First Nations pharmacy leaders
Medical & Science: NACCHO has announced the recipients of the 2024 Aboriginal and Torres Strait Islander Pharmacy Leadership Grant: Jes […]
MoreESG
First report exposes glaring gaps in healthcare sector sustainability
ESG: The first comprehensive report outlining sustainability and decarbonisation efforts in the Australian healthcare sector has been released, aimed at […]
MoreNews & Trends - Pharmaceuticals
Expanded access to Shingrix is a start: ‘We need reform for all current and future vaccines’
Pharma News: Access to GSK’s Shingrix vaccine, following the 2023-24 federal budget decision, has been limited to “immunocompromised patients aged […]
MoreNews & Trends - Pharmaceuticals
NSW government fails to back mental health inquiry findings with essential funding
NSW Government has support for 24 of 39 recommendations from the Portfolio Committee’s Inquiry Report on ‘Equity, accessibility and appropriate […]
More